NSE · UNIHEALTH · Healthcare
Unihealth Hospitals Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹137 Cr with net profit ₹26 Cr — a 18.85% net margin, versus 13.88% the period before.
Shareholding
As of 2026-03-31
- Promoter69.53%
- Public29.99%
- DII0.48%
1,162 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 6.14× from low to high.
Risk flags
Derived from disclosed data
- 52-week range spans 6.14× (₹133.65 to ₹819.95) — an unusually wide band.
Peer comparison
Healthcare · ranked #1 of 79 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,28,472 Cr | 242.67 | 13.55 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,08,166 Cr | 315.74 | 10.07 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,876 Cr | 270.47 | 7.26 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,315 Cr | 187.89 | 9.34 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,227 Cr | 299.63 | 9.23 | 8.48% | 8.36% |
| Global Health Limited | ₹38,526 Cr | 267.33 | 9.72 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,517 Cr | 135.03 | 8.94 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,558 Cr | 239.5 | 12.58 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹17,015 Cr | 256.67 | 5.47 | 10.37% | 17.18% |
| Dr. Agarwal's Health Care Limited | ₹15,494 Cr | 391.04 | 7.65 | 6.58% | 6.4% |
| Unihealth Hospitals Ltd.(this company) | — | 180.13 | 14.19 | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashUnihealth Hospitals Ltd. has a market capitalization of Rs 186 Cr. The company reported revenue of Rs 137.01 Cr and an EPS of 4.08. The stock's 52-week high is Rs 747.9 and its 52-week low is Rs 133.65.
Positives
- +Revenue increased by 14% to Rs 137.01 Cr.
- +Debt-to-equity ratio is low at 0.23.
- +Promoter holding is high at 69.5283% as of March 31, 2026.
- +There are no promoter shares pledged.
Negatives
- −The P/E ratio is high at 175.74.
- −The company's Roe (Return on Equity) data is not available.
- −No dividend yield information is available.
- −No quarterly results have been disclosed.
Financial Performance
Unihealth Hospitals Ltd. has seen its revenue grow by 14% to Rs 137.01 Cr. Annual revenue has increased consistently, from Rs 37.9269 Cr in March 2022 to Rs 137.0123 Cr in March 2026. Net profit has also shown a growth trend, reaching Rs 25.8303 Cr in March 2026 from Rs 3.8202 Cr in March 2022.
Profitability & Returns
The company's P/E ratio stands at 175.74. The Return on Capital Employed (ROCE) is 17.31%. Earnings per share (EPS) for the latest period is 4.08, following annual EPS figures that increased from 3.56 in March 2022 to 16.52 in March 2026.
Balance Sheet
The book value per share is Rs 51.79. The debt-to-equity ratio is 0.23, indicating that the company's operations are financed more by equity than debt. This suggests a relatively low reliance on borrowed funds.
Ownership & Pledges
Promoter holding is 69.5283% as of March 31, 2026. Public shareholding is 29.9876%. Institutional holding, including DIIs, is 0.4841%. There are no promoter pledges reported for Unihealth Hospitals Ltd.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.